TRS005

TRS005 · Zhejiang Teruisi Pharmaceutical Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for TRS005, covering 2025-06-25 to 2025-08-22. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Study of TRS005 in Patients With CD20-positive R/R DLBCL. [Phase 2]